MCX Or BSE, Zee Or Dainik Bhaskar? #AskBQ
#AskBQ is BloombergQuint's daily offering where market experts help investors make the right investment choice — be it in equities, commodities or the derivatives markets.
On Thursday's episode, Rahul Randeria of IFCI Financial Services and Sandeep Jain of Tradeswift Broking gave their views on BPL, Force Motors, MCX, and many more.
Watch the full conversation here:
Edited excerpts from the conversation:
Saurabh Shukla: I bought 1,000 shares of BPL at Rs 117 apiece with a long-term view. Should I hold or sell?
Sandeep Jain: I would recommend the investor to hold, and buy more on declines.
Amarjit Singh: I bought 20 shares of Force Motors at Rs 3,375 apiece with a long-term view. What should I do?
Rahul Randeria: I recommend the investor to remain invested for another year at least, with a stop loss of Rs 3,200.
Sandeep Jain: The investor can continue to hold as the risk reward ratio is good with a target of Rs 4,500-Rs 4,800 in the years to come.
Shubham Gupta: Is it the right time to invest in Setco Automotives with a long-term view?
Rahul Randeria: The investor can accumulate at Rs 56-58 levels, with a stop loss of below Rs 49.
Rishi Gadhiya: I bought 200 shares of Sterlite Tech at Rs 120. Should I continue to hold?
Rahul Randeria: I would advise to hold onto the stock with a stop loss below Rs 240.
Arpit Maheshwari: I bought 400 shares of Reliance Infra at Rs 520 with a long-term perspective. What should I do?
Sandeep Jain: The investor can continue to hold onto the stock, considering the renewed focus in Anil Dhirubhai Ambani-owned companies. I recommend Reliance Industrial Infra as well.
Aayush Malik: What is your view on ICICI Bank?
Rahul Randeria: If the investor has invested in the stock, I would advise him to hold onto it with a stop loss of Rs 295 and take a review once it breaks Rs 320 levels.
Mashahir Ahmed: I bought 500 shares of SKM Egg Products at Rs 94 with a long-term view. What should I do?
Rahul Randeria: The investor can continue to hold onto the stock as it is poised for a turnaround, with a stop loss of Rs 50.
Viren Kashyap: Is it the right time to invest in BSE and MCX with a long-term view?
Sandeep Jain: One can certainly invest in both the stocks at current levels. However, of the two, I would recommend MCX.
Prashant Joshi: I bought 20 shares of Ajanta Pharma at Rs 1,354 apiece with a three-month view. Should I hold or sell?
Rahul Randeria: The investor can remain invested with a stop loss of Rs 1,360 and long-term target of Rs 1,622.
Sameer Das: I bought 100 shares of DHFL at Rs 620 apiece. What should I do?
Rahul Randeria: The investor can continue to hold on with a stop loss of Rs 568, and can take a review once the stock breaches Rs 630.
Gaurav Garodia: What is your view on Claris Lifesciences?
Rahul Randeria: The investor can hold on and wait for some pullback, or exit on rallies. Recommend Aurobindo Pharma instead.
Rahul K: What is your view on Zee Media?
Sandeep Jain: The valuations are not very comfortable, recommend Dainik Bhaskar instead.
Bighnaraj Mishra: I bought 1,000 shares of Bhushan Steel at Rs 100 apiece. What should I do?
Sandeep Jain: The investor can buy at these levels, but not for long-term , only for encashing on rallies.
Here's how you can get your queries answered:
- Tweet us your queries using #AskBQ
- WhatsApp us on +91-8291229686
- Call us on 022-45404141
- Email us on askbq@bloombergquint.com
Analysts' Disclosure:
- Rahul Randeria said he does not have any financial interest and does not hold any stocks that were discussed today.
- Sandeep Jain said he does not have any personal holdings in any of the stocks discussed.
Disclaimer: The commentary on BloombergQuint represents the view of external experts. Investors are advised to consult a certified financial advisor/planner when making any investments. No views shared on a BloombergQuint program or story or conversation should be construed as personal advice.
Quintillion Business Media Pvt. (BloombergQuint) is not responsible for any risk or loss that might occur as a result of using this information in any way, regardless of your interpretation of the advice.
BloombergQuint's digital and social media platforms provide views of only SEBI registered investment advisors/analysts.
-
Where You Live Shapes How You Get To Work | The Reason Why
Two-wheelers are the most popular way to get to work in India, accounting for nearly 43% of workplace commutes.
-
High US Salaries, No Green Card Certainty: The Financial Calculation Facing Indian H-1B Families
The suspension of PERM processing at eight technology employers does not cancel existing H-1B visas. What it does is force a question many Indian families have been avoiding: is the US salary worth tying your career and family plans to one employer?
-
Unhedged Position: Can India See An Indonesia-Style Time Correction?
The Nifty is trading below levels it first clocked in 2024. Is there, then, as I have suggested in the headline, potential that the current time correction drags on painfully for the next three-five, even ten years?
-
Navigating Friction And Energy Realities: An Analysis Of Marco Rubio's October Visit To India
Occurring at a critical juncture marked by stalled trade negotiations and escalating geopolitical pressures over global energy supplies, the visit offers a profound window into modern US-India relations.
-
India Exports Capital. Why Not Export Trusteeship?
The big question, then, is whether India can build an institution that global borrowers, investors, banks, and lawyers can trust, even without an Indian connection.
-
France's Economy & Politics Are In Crisis | The Reason Why
Let's look at how the French economy and politics evolved under Nicolas Sarkozy, Franois Hollande and Emmanuel Macron.
-
You May Inherit The Business. You Must Earn Its Credibility.
Succession tests the founder's ability to share authority as much as it tests the next generation's readiness to assume it.
-
Signing Deals Is One Thing; Making Them Work Is Another | The Week In Whys
Sometimes, things don't turn out as planned. Indian companies have lost some bids to rivals, some projects won't produce until 2030.
-
FOMC Wall, PERM Suspension, Hospital Stocks | Talking Points This Week
A PERM suspension would directly affect green-card sponsorship rather than H-1B visas, so the near-term earnings impact could remain relatively limited. The key question is whether this marks a new phase in US scrutiny of Indian IT.
-
Everything, Everywhere, All At Once: Dalal Street's Week To Forget | Joining The Dots
Visa curbs, a Starlink spat and cancer drug caps: what connects this week's shocks for Indian markets